Navigation Links
Hepatitis E takes a piggyback

Pigs carry hepatitis E virus (HEV), which they can pass on to humans. But now research from Japan published in Online Open Access journal BMC Veterinary Research says that pigs get HEV early enough to minimise the risk of human infection. The scenario humans need to worry about would occur if the infection rate in pigs drops. At low infection rates, there is actually a higher chance pigs will pass on HEV to humans at slaughter.

Kunio Satou and Hiroshi Nishiura analysed blood test data from 2,500 pigs, natural hosts for the virus, on Japanese farms at Hokkaido, Honshu and Kyushu. They found that by the age of 150 days, over 95% of pigs had been infected with HEV.

Inoculation studies have shown that the virus remains in pigs?faeces and some organs for up to 30 days after infection. This means that the chances of pigs excreting the virus when they are slaughtered at the age of 180 days are currently small. However, if the infection weakens and pigs don’t get infected with HEV until they are older, more pigs will still be carrying the virus when they reach the slaughterhouse.

HEV, which is found worldwide, can potentially cause acute hepatitis in humans. So monitoring infection rates could help protect meat processors and vets. The disease can be transmitted by drinking water contaminated with faeces as well as by eating pork: uncooked wild boar liver is one Japanese delicacy that frequently leads to infection.

Suckling pigs don't contract the virus in their first 30 days, because a maternal antibody protects them. Vaccines are currently under development against HEV, although Satou and Nishiura suggest that changes in husbandry practices and avoiding eating raw liver might be more cost-effective measures should HEV’s hold on pig farms weaken.
'"/>

Source:BioMed Central


Page: 1

Related biology news :

1. Scientists Replicate Hepatitis C Virus in Laboratory
2. Norovirus, AIDS vaccine and Hepatitis Virus
3. UCLA study assesses cost-effectiveness of Hepatitis B drugs
4. Natural Killers Could Lead to New Hepatitis Treatments
5. FDA Approves New Treatment for Chronic Hepatitis B
6. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
7. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
8. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
9. Hepatitis C complicated by morphine withdrawal
10. Hepatitis B accounts for 40 percent of missing Asian women
11. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology: